CH · biotech · healthcare · medical device
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Series A · Jun 2025 · $80M
EQT Life Sciences lead, Pivotal bioVenture Partners lead, Norwest, High-Tech Gründerfonds (HTGF), Forbion, Broadview Ventures, Forty51 Ventures, Supermoon Capital
Reported by Silicon Canals
Missing a round, or an investor who was in one? Tell us.